Bone Biologics Corp — Form 8-K
Filed July 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Bone Biologics Corp filed an 8-K on July 16, 2026 (reporting period July 15, 2026) containing Item 8.01 Other Events. The actual substance of the disclosure is not provided in the filing metadata—only the form structure, XBRL data files, and company registration information are shown. No dollar amounts, counterparties, dates of material transactions, or specific business developments are disclosed in this excerpt.
Why this rating
Item 8.01 is typically routine/boilerplate. Actual event details are absent from available text, preventing assessment of materiality relative to $7.2M company scale.
Extracted items
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.